Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
26.52
-0.29 (-1.08%)
At close: Sep 25, 2026, 4:00 PM EDT
26.49
-0.03 (-0.11%)
After-hours: Sep 25, 2026, 7:55 PM EDT
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.88 billion as of September 25, 2026. Its market cap has increased by 53.59% in one year.
Market Cap
1.88B
Enterprise Value
1.58B
1-Year Change
53.59%
Ranking
Category
Stock Price
$26.52
ChartMarket Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.88B, an increase of 471.29%. That is a compound annual growth rate of 20.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 1.88B | -4.50% |
| Dec 31, 2025 | 1.97B | 95.40% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 2.02B |
| Vericel | 2.01B |
| Nuvation Bio | 2.01B |
| Biohaven | 1.99B |
| Maravai LifeSciences Holdings | 1.99B |
| Lakefront Biotherapeutics NV | 1.97B |
| Mesoblast | 1.97B |
| Agios Pharmaceuticals | 1.96B |